August 13, 2025, marks the first-ever Generalized Pustular Psoriasis (GPP) Awareness Day. It is a key part of a new campaign aimed at increasing awareness and education about GPP, led by the National Psoriasis Foundation and Boehringer Ingelheim.Here, GPP patient Toshia Peterson shares her story with Springfield, OH-based Dermatologist Shannon C. Trotter, DO. Peterson, a medical assistant and mother of three, spent nearly 20 years seeking answers. Her flares were misdiagnosed as lice or folliculitis until she finally received a GPP diagnosis and effective treatment. “I’m not alone anymore. I’m being heard. I have a day of awareness to talk to other people, [and] a sense of community support. That’s what the GPP Awareness Day means to me,” she says.
Key Takeaways
- GPP is rare, affecting one of every 10,000 people in the US
- GPP and plaque psoriasis are distinct diagnoses
- Early diagnosis and treatment of GPP is key
- While a biopsy can be helpful, taking a thorough medical history is essential to making a GPP prompt diagnosis
- For more information, patients can visit GPP & Me
